[ORGANIZATION]
Chimagen Biosciences
Featured in 1 tracked story · first seen
Also covered in
-
GSK acquires Chimagen myeloma T-cell engager for up to $750M
[BUSINESS] · 3 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[BUSINESS] · 3 sources ·